SHELBY COCHRAN: Open Payments
NPI 1700343209 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,478 in 176 payments from 20 companies in 2025. Trend: 2023 $2,677 · 2024 $3,691 · 2025 $13,478
Speaker / faculty: $5,400Food & beverage: $5,042Travel & lodging: $1,956Consulting: $1,080
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 26 | $8,802 |
| Enterra Medical, Inc. | 5 | $1,201 |
| ABBVIE INC. | 46 | $763 |
| Ipsen Biopharmaceuticals, Inc | 12 | $396 |
| Regeneron Healthcare Solutions, Inc. | 8 | $354 |
| Phathom Pharmaceuticals, Inc. | 8 | $320 |
| Janssen Biotech, Inc. | 16 | $310 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $308 |
| Janssen Scientific Affairs, LLC | 3 | $272 |
| Organon LLC | 9 | $230 |
Products named: REZDIFFRA, TREMFYA, IQIRVO, RINVOQ, DUPIXENT, VOQUEZNA, XIFAXAN, HADLIMA.
Industry payments across AR — which companies pay providers there.
